CapVest Partners is close to striking a deal to acquire Stada Arzneimittel AG for about €10 billion ($11.7 billion) including debt, Bloomberg reported on Sunday, citing people familiar with the matter.
The London-based buyout firm is finalising terms with Stada’s private equity owners Bain Capital and Cinven, and an announcement could come as soon as Monday if talks do not falter, Bloomberg said.
Previous negotiations stumbled over valuation and legal liabilities, prompting Bain and Cinven to consider an initial public offering before CapVest returned to the table, according to the report.
A deal would mark one of the biggest private equity exits in Europe this year, at a time when firms are under pressure to sell long-held assets and return capital to investors.
Stada, bought by Bain and Cinven for €5.3 billion in 2017, makes consumer health products, generic medicines, and specialty drugs.
source :
